baber/WOPTO huggingface dataset:
Patent NZ-567815-A (NZ)
Title: Training neural networks including selecting an output to be trained and connecting an output neuron to input neurons
Inventor: GARNER BERNADETTE
IPC: G06N3/08
Filed: 2006-11-15
Abstract: A method for training an artificial neural network (NN) includes the steps of: initialising the NN by selecting an output of the NN to be trained and connecting an output neuron of the NN to input neuron(s) in an input layer of the NN for the selected output; preparing a data set to be learnt by the NN; and, applying the prepared data set to the NN to be learnt by applying an input vector of the prepared data set to the first hidden layer of the NN, or the output layer of the NN if the NN has no hidden layer(s), and determining whether at least one neuron for the selected output in each layer of the NN can learn to produce the associated output for the input vector. If none of the neurons in a layer of the NN can learn to produce the associated output for the input vector, then a new neuron is added to that layer to learn the associated output which could not be learnt by any other neuron in that layer. The new neuron has its output connected to all neurons in next layer that are relevant to the output being trained. If an output neuron cannot learn the input vector, then another neuron is added to the same layer as the current output neuron and all inputs are connected directly to it. This neuron learns the input the old output could not learn. An additional neuron is added to the next layer. The inputs to this neuron are the old output of the NN, and the newly added neuron to that layer.
Patent NZ-574445-A (NZ)
Title: Growing platform device and method
Inventor: PRACEY DERRICK
IPC: E02D3/00
Filed: 2009-07-27
Abstract: A soil retention device 1 comprises a planar, crescent shaped central section with the first edge 10 shorter than the second opposite edge 11. The central section has one or more apertures 30 that allow water to drain when the device is in use.
Patent NZ-577259-A (NZ)
Title: Improvements in or relating to tube couplings
Inventor: GUEST TIMOTHY STEPHEN
IPC: F16L21/04
Filed: 2009-05-27
Abstract: A tube coupling includes a coupling body 10 having an open ended throughway 11 to receive a tube 16. A collet 20 is located in the open end of the throughway having a ring 21 and a plurality of flexible arms 22 extending into the throughway. The throughway has a tapered cam surface 25 convergent towards the open end and the collet arms have heads 23 at their distal ends for engaging both the cam surface and a tube extending through the collet into the throughway to be compressed against the tube by the cam surface with outward movement of the collet with respect to the throughway to secure the tube in the throughway. A collet lock 27 is rotatably mounted on the coupling body having one rotary position in which the lock holds the collet 20 and another rotary position in which the collet can move axially.
Patent NZ-582271-A (NZ)
Title: Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
Inventor: KONDO KAZUNARI
IPC: A61K39/12
Filed: 2008-06-25
Abstract: Disclosed is a vaccine antigen capable of inducing a cross-reacting and neutralizing antibody directed against a high-risk-type human papillomavirus. Specifically disclosed are: a chimeric protein comprising an L2-epitope of a human papillomavirus (HPV) type-16 inserted in a loop region of a human papillomavirus type-16 L1 protein; and a capsid which is an aggregate of the chimeric protein. The loop region to which the L2-epitope is to be inserted is located between an amino acid residue at position-430 and an amino acid residue at position-433. The L2-epitope has an amino acid sequence represented by any one of the following formulae: LYKTCKQAGTCPPDIIPKVEG (18-32 L2-epitope); GGLGIGTGSGTGGRTGYIPL (56-75 L2-epitope); and DPVGPLDPSIVSLVEESSFI (96-115 L2-epitope).
Patent NZ-582678-A (NZ)
Title: Apparatus for filtering a liquid with a drum and filter sets with a fluid passageway to vent the filter sets
Inventor: DAVIS WILLIAM E
IPC: C12M1/34
Filed: 2008-07-16
Abstract: Disclosed is a filter having a vent for inhibiting formation of a vacuum in the filter. The filter includes a drum for receiving the liquid, the drum including a drum headspace (470). The filter also includes filter sets (300) for filtering the liquid. The drum is rotated to enable cleaning of filter media. The filter device also includes a frame having spaced apart supports (430) for supporting each of the filter sets. A fluid passageway (440) extends between the supports, wherein the fluid passageway provides fluid communication between the tank headspace and a filter set to vent a filter set.
Patent NZ-590732-A (NZ)
Title: Methods of treating an overweight or obese subject using fumagillin
Inventor: VATH JAMES
IPC: A01N37/18
Filed: 2009-07-17
Abstract: Disclosed are pharmaceutical formulations and methods of treating an overweight or obese subject, and overweight- or obesity-related conditions.
Patent NZ-590852-A (NZ)
Title: Pharmaceutical formulations containing dopamine receptor ligands trans-1{ 4-[2-[4-(2,3-dichlorophenyl)-piperizin-1-yl]-ethyl]-cyclohexyl} -3,3-dimethyl-urea also known as cariprazine
Inventor: SARKAR RANAJOY
IPC: A61K31/55
Filed: 2009-07-16
Abstract: Disclosed is a pharmaceutical formulation in a solid oral dosage form comprising trans-1{ 4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl } -3,3-dimethyl-urea, or a pharmaceutically acceptable salt thereof, and a buffering agent or an excipient having low water activity, and wherein the formulation comprises less than about 1 per cent w/w trans-4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl-amine, or a pharmaceutically acceptable salt thereof. Also disclosed is pharmaceutical formulation comprising from about 0.05 to about 15 mg trans-1{ 4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl} -3,3-dimethyl-urea, or a pharmaceutically acceptable salt thereof, wherein the formulation provides an in vivo plasma profile comprising: (i) a mean Cmax of less than about 26.3 nglmL, (ii) a mean AUC 0 infinity of more than about 2 ng.hr/mL and (iii) a mean T max of about 3 or more hours.
Patent NZ-600660-A (NZ)
Title: Macrocyclic lactone derivatives for the treatment of cancer
Inventor: MOHAMMED ABDUL SHAFEE
IPC: C07D313/00
Filed: 2010-11-15
Abstract: 600660 Disclosed herein are compounds represented by formula (1): wherein, R1, R2, R3 and R4 are as defined in the specification, in all their stereoisomeric and tautomeric forms and mixtures thereof in all ratios, and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable polymorphs and prodrugs. Also disclosed are processes for the manufacture of compounds of formula (1) and pharmaceutical compositions containing them. The compounds and the pharmaceutical compositions of the present invention are useful for the treatment of cancer. Additionally disclosed is a method of treatment of cancer by administering a therapeutically effective amount of the said compound of formula (1) or its pharmaceutical composition, to a mammal in need thereof.
Patent NZ-602765-A (NZ)
Title: Therapeutic delivery devices, systems, and methods
Inventor: FINEBERG DAVID
IPC: A61M25/10
Filed: 2011-03-03
Abstract: 602765 – Coaxial infusion catheter system A coaxial catheter system includes an infusion catheter 3 component and an occlusion catheter component 2 at least a portion of which is coaxially positioned within the infusion catheter 3. The occlusion catheter provides for occlusion of a vessel or graft distal to an occlusion. A composition including a thrombolytic agent can be infused into an annular fluid passageway between the outer wall of the occlusion catheter and the inner wall of the infusion catheter to provide the agent to a treatment zone.
Patent NZ-604514-A (NZ)
Title: Dual rigidity shoe sole
Inventor: TORRANCE TONY L
IPC: A43B13/12
Filed: 2011-06-17
Abstract: Disclosed are a midsole (412) and an outersole (416) for an article of footwear. The disclosure notes that shoes for mountain biking have a more flexible sole which leads to inefficiencies and loss of energy when pedalling, whereas the present midsole (412) is flexible but also efficiently transfers energy between a riders foot and a pedal. The midsole (412) comprises a metatarsal region (451, 452, 453) and a cleat region (436). The metatarsal region (451, 452, 453) comprises a first material. The cleat region (436) comprises at least a portion of the metatarsal region (451, 452, 453) and a second material. The second material is more rigid than the first material.
Patent NZ-609533-A (NZ)
Title: Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
Inventor: STARK MARCUS
IPC: A61K31/41
Filed: 2007-10-04
Abstract: Disclosed herein is the use of an angiotensin II receptor 1 (AT-1) antagonist for the manufacture of a pharmaceutical composition comprising a therapeutically effective amount of said AT-1 antagonist for the treatment of a systemic disease in cats, wherein the systemic disease is selected from the group of cardiovascular diseases, vascular diseases, and metabolic disorders, wherein said angiotensin II receptor (AT-1) antagonist is a sartan selected from the group consisting of: candesartan, eprosartan, irbesartan, losartan, tasosartan, telmisartan, valsartan, and a pharmaceutically acceptable salt thereof.
Patent NZ-611865-A (NZ)
Title: Pyrazole derivative
Inventor: NOZAWA DAI
IPC: A61P43/00
Filed: 2011-12-16
Abstract: Provided are pyrazole derivative compounds of the general formula (IA) where R3 is a triazolyl, pyridyl or pyrimidinyl and the other variables are as defined in the specification. Examples of the compounds include N-{ 2-[4-(5-fluoropyridin-2-yl)-1H-pyrazol-1-yl]ethyl} -5-methyl-2-(2H-1,2,3-triazol-2-yl)benzamide and N-ethyl-5-fluoro-2-(pyrimidin-2-yl)-N-(2-{ 3-[4-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-1-yl} ethyl)benzamide. The compounds are orexin (OX) receptor antagonists. The compounds may be useful in the treatment of sleep disorders, depression, anxiety disorders, panic disorders, schizophrenia, drug dependence, Alzheimer’s disease, Parkinson’s disease, Huntington’s chorea, eating disorders, pain, gastrointestinal diseases, epilepsy, inflammation, immune-related diseases, endocrine-related diseases and hypertension.
Patent NZ-615383-A (NZ)
Title: Methods and devices for cellular transplantation
Inventor: LEUSHNER JUSTIN
IPC: A61L27/56
Filed: 2010-08-27
Abstract: 615383 Devices and methods for transplanting cells in a host body are described. The cell comprises a porous scaffold that allows ingrowth of vascular and connective tissues, a plug or plug system configured for placement within the porous scaffold, and a seal configured to enclose a proximal opening in the porous scaffold. The device may further comprise a cell delivery device for delivering cells into the porous scaffold. The method of cell transplantation comprises a two step process. The device is incubated in the host body to form a vascularized collagen matrix around a plug positioned within the porous scaffold. The plug is then retracted from the porous scaffold, and cells are delivered into the vascularized space created within the porous scaffold.
Patent NZ-616559-A (NZ)
Title: Headgear for masks
Inventor: DRAVITZKI BRENT
IPC: A62B18/08
Filed: 2009-12-10
Abstract: A headgear 60 for use in holding a respiratory mask 10 in position on a patient’s face for positive pressure treatment of the patient, comprises a rear portion configured to engage a back of a patient’s head and further comprises respective left and right side portions. The rear portion includes a first portion 40 arranged to align substantially parallel with a top of the patient’s head in use and a second portion 50 arranged to align substantially parallel to a rear surface of the patient’s head. The rear portion has a first extensibility, and is constructed to resiliently return to a predetermined shape when not in use. At least one of the left or right side portions have a different extensibility to the rear portion. The respective left and right side portions each comprise a top strap 20 and a bottom strap 30, where the bottom strap 30 of the left side portion and the bottom strap of the right side portion are constructed and arranged to extend along a side of a patient’s head below an ear in use, and the top strap 20 of the left side portion and the top strap of the right side portion are constructed and arranged to extend along a side of a patient’s head above an ear in use.
Patent NZ-619030-A (NZ)
Title: Mechanism and chair for powered combined and independent seat back and leg rest motion
Inventor: MARSHALL RICHARD E
IPC: A47C17/04
Filed: 2012-08-23
Abstract: A furniture member mechanism includes a first actuator device electrically operated to displace first and second seat back actuation links connected to and operating to rotate a seat back member between upright and fully reclined positions. A pantograph linkage set connected to a leg rest member is at least partially supported in an extended position by rotational contact with a support rod. A second actuator device identical to the first actuator device is electrically operated to axially rotate a drive rod connected to a drive link. The drive link is connected to and displaces the pantograph linkage set between the stowed and extended positions. A swing lever rotatably connected to the support rod is rotated during operation of the second actuator device to extend the pantograph linkage set. The swing lever in a fully rotated position displaces the support rod creating a furniture member tilt position.
Patent NZ-710311-A (NZ)
Title: Parking meter and method of monitoring and managing parking
Inventor: HUDSON THOMAS
IPC: G07F17/24
Filed: 2014-01-25
Abstract: The present invention relates to parking meters and more particularly to automated parking meter systems. The present invention seeks to improve parking control and related revenue by monitoring and managing parking meters. The present invention provides an arrangement whereby the meter displays that a parking violation has occurred, displays the amount of the fine due, and accepts payment of the fine. The present invention relates to a parking meter that comprises a weather resistant housing having a first side and a second side, a processor disposed inside of the housing, a memory disposed inside of the housing and coupled to the processor, a network interface disposed in the housing and coupled to the processor, a graphical user interface disposed in the housing and facing outward from the first side of the housing, a first camera disposed in the housing and facing outward from the first side of the housing and being coupled to the processor, a microphone disposed in the housing, a speaker disposed in the housing, a second camera disposed in the housing and facing outward from the second side of the housing towards a first parking space and being coupled to the processor, a first status light disposed on the housing and coupled to the processor, and a payment acceptor disposed in the housing. The processor is configured to detect a vehicle’s presence in the first parking space, capture an identification of the vehicle in the first parking space, transmit the identification to a remote computer system via the network interface, time an initial grace period, receive payment for a parking time period, determine that a parking violation has occurred due to at least one of the initial grace period expiring without receiving payment for the parking time period and the parking time period expiring without the vehicle exiting the first parking space, actuate the status light to provide a visual indication that a violation has occurred, transmit notice of the parking violation to the remote computer system via the network interface where the notice includes the vehicle’s identification and a time of the violation, accept payment of a fine for the parking violation via the payment acceptor, transmit notice of payment of the fine to the remote computer system via the network interface, transmit a time of the vehicle’s exit from the first parking space to the remote computer system via the network interface, reset the parking time period to zero upon the vehicle’s exit from the first parking space, and receive updated parking rate parameters from the remote computer system via the network interface. The present invention also relates to a method of monitoring and managing parking via such a parking meter.
Patent NZ-715417-A (NZ)
Title: Formwork panel for concreting formworks
Inventor: HOLLMANN KAI
IPC: E04G11/08
Filed: 2014-07-09
Abstract: Formwork panels for concrete-work shutterings are known in a large variety of designs. Composite formwork panels mostly consist of a carrier grating (frame) made of wooden beams, of steel beams or of aluminium beams, and a formwork skin attached to the carrier grating on one side of the same. The formwork skin as a rule has a shorter lifetime than the carrier grating and, in particular due to wear, damage or fatigue, is replaced after a certain number of uses of the form-work panel. With known composite formwork panels, the form-work skin mostly consists of a multilayer plywood; however, there are also form-work skins known in the form of a composite construction of plywood lay-ers/plastics layer or aluminum layer/plastic layers or glass fiber mats/plastic layers. The present invention provides in one aspect a formwork panel for concrete-work shutterings, the formwork panel comprising: a supporting structure substantially of plastics material, wherein the supporting structure is substantially in the form of a grating with openings that are open both towards the front side of the supporting structure and towards the rear side of the supporting structure; and a separate formwork skin which is constituted by a single formwork skin element substantially of plastics material or by several formwork skin elements substantially of plastics material each; wherein the formwork skin is releasably connected to the supporting structure and comprises at least one formwork skin element with molded-on extensions on its rear side, which are releasably affixed to the supporting structure. As mentioned above, the formwork skin of a formwork panel is subject to aging and the formwork skin has to be replaced after a certain number of uses of the formwork panel. The formwork panel according to the present invention allows replacement in a particularly unproblematic manner in the light of the structure of the formwork panel according to the invention.
Patent NZ-720321-A (NZ)
Title: Container apparatus
Inventor: SKINNER LESLIE JOHN
IPC: B65D5/36
Filed: 2014-10-24
Abstract: An expanded polystyrene container consists of a substantially planar blank having a plurality of regions, the regions including a base, side walls, end walls and a lid. The blank is able to be converted into a first unassembled configuration in which regions of the blank are pivoted around the hinges connecting the regions in relation to other regions, to form a rectangular slab in which compact mode blanks are able to be stacked, and a second configuration in which the blank is erected to form the container, which has a cuboidal structure of substantially uniform cross-section, for the storage of articles. The hinge comprises a recess the recess defining a point of minimum cross section. The base of a container may also include ledge portions at each of the comers of the base, which ledge portions provide support for hinges.
Patent NZ-722791-A (NZ)
Title: Integration of a polynucleotide encoding a polypeptide that catalyzes pyruvate to acetolactate conversion
Inventor: ANTHONY LARRY
IPC: C12N1/21
Filed: 2011-09-07
Abstract: Disclosed is a recombinant host cell comprising: (a) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of pyruvate to acetolactate wherein the polypeptide is an acetolactate synthase from Bacillus subtilis, Klebsiella pneumonia, Lactococcus lactis, Staphylococcus aureus, Listeria monocytogenes, Streptococcus mutans, Streptococcus thermophiles, Vibrio angustum, or Bacillus cereus which has at least 95% identity to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16 or 18; (b) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of acetolactate to 2,3-dihydroxyisovalerate wherein the polypeptide is a ketol-acid reductoisomerase from Anaerostipes caccae which has at least 95% identity to SEQ ID NO: 224; (c) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of 2,3-dihydroxyisovalerate to α-ketoisovalerate wherein the polypeptide is a dihydroxyacid dehydratase from Escherichia coli, Bacillus subtilis, Methanococcus maripaludis, or Streptococcus mutans which has at least 95% identity to SEQ ID NO: 89; and (d) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of α-ketoisovalerate to isobutyraldehyde wherein the polypeptide is a branched-chain α-keto acid decarboxylase from Listeria grayi which has at least 95% identity to SEQ ID NO: 247.
Patent NZ-728163-A (NZ)
Title: Method for successively performing hair dyeing and hair straightening
Inventor: SHIODA MASATAKA
IPC: A61Q5/10
Filed: 2014-09-26
Abstract: A method for conducting hair dying and curly hair straightening continuously, said method being characterized by comprising the steps of: subjecting hair to a dying treatment; applying a reducing first preparation containing a basic dye and/or an HC dye onto the hair immediately after the dying treatment and then allowing the hair to leave for a predetermined time to achieve a reduction treatment of a cystine bond; straightening the reduced hair; applying an oxidizing second preparation onto the straightened hair and then allowing the hair to leave for a predetermined time to achieve an oxidization treatment for regenerating the cystine bond.
Patent NZ-747870-A (NZ)
Title: Dynamic deactivation of cold database in database service
Inventor: TALIUS TOMAS
IPC: G06F9/50
Filed: 2017-06-27
Abstract: Managing databases implemented in a cloud computing environment. A method includes detecting that a database implemented in the cloud computing environment is in a state of non-use. The method further includes as a result of detecting that a database implemented in the cloud computing environment is in a state of non-use, instantiating a workload in the cloud computing environment to deactivate the database. The workload is configured to store metadata for the database and database data remotely in cloud storage such that the database can be reactivated at a later time.
Patent NZ-749557-A (NZ)
Title: 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides
Inventor: LORSBACH BETH
IPC: A61K31/513
Filed: 2013-12-23
Abstract: This present disclosure is related to the field of 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1H)-ones (Formula I) and their derivatives, to the use of these compounds as fungicides, and to the efficient process of preparing these compounds.